Pathogenic Provirus of Sivmac

Haseltine, William A.

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Institute of Allergy and Infectious Diseases (NIAID)
• Type: Research Project (R01)
• Project #: 3R01AI029333-01S1
• Application #: 3144106
• Study Section: Special Emphasis Panel (ARR (V1))
• Project Start: 1990-03-01
• Project End: 1993-02-28
• Budget Start: 1990-03-01
• Budget End: 1991-02-28
• Support Year: 1
• Fiscal Year: 1991

Institution

• Name: Dana-Farber Cancer Institute
• DUNS #: 149617367
• City: Boston
• State: MA
• Country: United States
• Zip Code: 02215

Publications

Letvin, N L; Li, J; Halloran, M et al. (1995) Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus. J Virol 69:4569-71

Park, I W; Sodroski, J (1995) Amino acid sequence requirements for the incorporation of the Vpx protein of simian immunodeficiency virus into virion particles. J Acquir Immune Defic Syndr Hum Retrovirol 10:506-10

Park, I W; Sodroski, J (1995) Functional analysis of the vpx, vpr, and nef genes of simian immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol 8:335-44

Voss, G; Li, J; Manson, K et al. (1995) Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys. Virology 208:770-5

Pelletier, E; Saurin, W; Cheynier, R et al. (1995) The tempo and mode of SIV quasispecies development in vivo calls for massive viral replication and clearance. Virology 208:644-52

Park, I W; Myrick, K; Sodroski, J (1994) Effects of vif mutations on cell-free infectivity and replication of simian immunodeficiency virus. J Acquir Immune Defic Syndr 7:1228-36